Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung CancerInterventions: Drug: imetelstat; Drug: BevacizumabSponsor: Geron CorporationRecruiting - verified August 2010






